Extensive clinical experiences with stem cells, particularly for the treatment of hematological diseases, have suggested the use of stem cells to treat nonhematopoietic diseases. Mesenchymal stem cells (MSCs) have shown promise for regeneration and repair of many tissues. Due to their presence in all organs, their easy isolation, as well as their pluripotency, MSCs are considered an important focus of current and future cell therapies for regenerative medicine.

In this issue, we invite authors to discuss the potential use of MSCs for (1) tissue regeneration in nonhematopoietic diseases, (2) development of preclinical and clinical models for nonhematopoietic diseases, and (3) study of their intrinsic properties: molecular, cellular, immunological, and differentiation capabilities. We invite submission of papers. Potential topics include, but are not limited to:

• Solid organ cancer
• Cardiomyopathy
• Neurodegenerative disease
• Neuromuscular disease
• Stroke
• Spinal cord and brain trauma
• Skin disease and wound healing
• Bone disease
• Tissue engineering
• Bioartificial organs

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/sci/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/sci/mesen/ according to the following timetable: